Bordeaux Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.49M Sell
1,906
-293
-13% -$228K 0.19% 47
2025
Q1
$1.82M Buy
2,199
+1,005
+84% +$836K 0.34% 41
2024
Q4
$922K Buy
1,194
+140
+13% +$116K 0.15% 58
2024
Q3
$934K Buy
1,054
+377
+56% +$339K 0.17% 58
2024
Q2
$613K Buy
677
+27
+4% +$21.6K 0.12% 72
2024
Q1
$506K Sell
650
-45
-6% -$32K 0.17% 57
2023
Q4
$405K Buy
695
+88
+14% +$51.4K 0.14% 70
2023
Q3
$326K Buy
607
+103
+20% +$53.1K 0.13% 72
2023
Q2
$236K Buy
+504
New +$211K 0.1% 89

Other funds holding LLY

Bordeaux Wealth Advisors's LLY Position: Q2 2025 in Review

Bordeaux Wealth Advisors reduced its Eli Lilly (LLY) stake by 13% in Q2 2025, selling an estimated $228K and leaving 1,906 shares worth $1.49M. The position accounts for 0.19% of the portfolio, ranked #47.

Bordeaux Wealth Advisors first reported a position in LLY in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.82M in Q1 2025. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Bordeaux Wealth Advisors held 1,906 shares of Eli Lilly worth $1.49M as of Q2 2025.
  • Bordeaux Wealth Advisors sold 293 Eli Lilly shares in Q2 2025, an estimated $228K.
  • Eli Lilly made up 0.19% of Bordeaux Wealth Advisors's portfolio in Q2 2025, its #47 holding.
  • Bordeaux Wealth Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 9 quarters since.
  • Bordeaux Wealth Advisors's Eli Lilly position peaked at $1.82M in Q1 2025.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Bordeaux Wealth Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.